Course info
Sections
General
0 activities
Education Program
0 activities
Bleeding Disorder of Unknown Cause—What Do We Know?
4 activities
Immune Cytopenias: Addressing Challenges and Advancing Treatments
4 activities
Now Is the Time to Improve Outcomes in Diffuse Large B-Cell Lymphoma
4 activities
Frontline Incorporation of Immune Targeting Agents in B-ALL: Triumphs and Challenges
4 activities
The Changing Landscape of the Care of Patients With Immune-Mediated and Congenital TTP
4 activities
Complementopathies: Modern Diagnosis and Management
4 activities
Down the Rabbit Hole: An Update on Histiocytic Disorders
4 activities
Between Clots and Complications: A New Era of Anticoagulation in Cancer
4 activities
Hemoglobinopathies and Increased Risk of Venous Thromboembolism
4 activities
Post-SCT Maintenance Strategies in Leukemia: Who, When, and Why?
4 activities
Rare Aggressive B-Cell Lymphomas: Challenge for a Pathologist, Challenge for a Clinician
4 activities
What's New and Current in the World of Bone Marrow Failure
4 activities
Treatment Refinement in Multiple Myeloma
4 activities
Challenges in Diagnosing and Managing Mucocutaneous Bleeding Disorders
4 activities
Our Patient Is Pregnant: Comanaging Obstetric Patients With Complex Hematologic Issues During Their Pregnancy and Delivery
4 activities
Arterial Disease and the Hematologist
4 activities
Sickle Cell Therapies: The Who, What, When, and Where
4 activities
Decoding the Enigma: Challenges in Classical Hematology Consultations
4 activities
Molecular Diagnostics for Clinical Classical Hematologists: When to Order, What to Order, What It Means, and When to Refer to Genetics?
4 activities
New Age Hematopoietic Stem Cell Transplantation: Same Donors, New Prophylaxis, Novel Engineering (Adult and Pediatric Perspectives)
4 activities
Invasion of the Immunotherapies: Where We Are and Where We Are Going in Leukemia, Lymphoma, and Myeloma
4 activities
Multiple Myeloma: What Is the Best Induction, Consolidation, and Maintenance for Fit vs. Non-Fit
4 activities
Update in Hemophilia Across the Lifespan: Novel Therapies/Gene Therapy/Issues in Older Patients
4 activities
Targeted Therapy for AML (Triplets and More)
4 activities
Genomics in Pediatric Acute Leukemia Risk Stratification
4 activities
Navigating Immunotherapies in Pediatric Leukemia and Lymphoma: CAR-Ts, allo-HSCT - How, When, and Why?
4 activities
Biology-Based Management of Iron Toxicity and Overload in Hematology Practice
4 activities
B-Cell Malignancies Common and Rare: What's New in Chronic Lymphocytic Leukemia and Rare B-Cell Disorders?
4 activities
Monoclonal Gammopathies of Clinical Significance
4 activities
29
87